These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 2311169

  • 1. The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology.
    Wang LM, White JC, Capizzi RL.
    Cancer Chemother Pharmacol; 1990; 25(6):418-24. PubMed ID: 2311169
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential effect of GM-CSF pretreatment on intracellular Ara-C metabolism in normal bone marrow mononuclear cells vs acute myeloid leukemia (AML) blasts.
    Reuter C, Schleyer E, Rolf C, Wörmann B, Büchner T, Hiddemann W.
    Leukemia; 1997 Apr; 11(4):561-71. PubMed ID: 9096697
    [Abstract] [Full Text] [Related]

  • 5. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM, Rustum YM.
    Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [Abstract] [Full Text] [Related]

  • 6. Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines.
    Noordhuis P, Kazemier KM, Kasperrs GJ, Peters GJ.
    Leuk Res; 1996 Feb; 20(2):127-34. PubMed ID: 8628011
    [Abstract] [Full Text] [Related]

  • 7. In vitro effects of bryostatin 1 on the metabolism and cytotoxicity of 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S, Boise L, Westin E, Howe C, Pettit GR, Turner A, McCrady C.
    Biochem Pharmacol; 1991 Jul 25; 42(4):853-67. PubMed ID: 1867641
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine.
    Grant S, Turner A, Nelms P, Yanovich S.
    Leukemia; 1995 May 25; 9(5):808-14. PubMed ID: 7769843
    [Abstract] [Full Text] [Related]

  • 9. Potential for selective enhancement of the in vivo metabolism of 1-beta-D-arabinofuranosylcytosine in rats by thymidine pretreatment.
    Danhauser LL, Rustum YM.
    Cancer Res; 1985 May 25; 45(5):2002-7. PubMed ID: 3986756
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.
    Abe I, Saito S, Hori K, Suzuki M, Sato H.
    Cancer Res; 1982 Jul 25; 42(7):2846-51. PubMed ID: 7083175
    [Abstract] [Full Text] [Related]

  • 12. Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor.
    Reuter C, Auf der Landwehr U, Schleyer E, Zühlsdorf M, Ameling C, Rolf C, Wörmann B, Büchner T, Hiddemann W.
    Leukemia; 1994 Feb 25; 8(2):217-25. PubMed ID: 8309245
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphate.
    Catapano CV, Chandler KB, Fernandes DJ.
    Cancer Res; 1991 Apr 01; 51(7):1829-35. PubMed ID: 1706219
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-B-D arabinofuranosylcytosine in highly resistant human leukemia cells.
    Bhalla K, Swerdlow P, Grant S.
    Blood; 1991 Dec 01; 78(11):2937-44. PubMed ID: 1954383
    [Abstract] [Full Text] [Related]

  • 16. Recombinant GM-CSF modulates the metabolism of cytosine arabinoside in leukemic cells in bone marrow.
    Tanaka M.
    Leuk Res; 1993 Jul 01; 17(7):585-92. PubMed ID: 8326741
    [Abstract] [Full Text] [Related]

  • 17. Modulation of the cellular pharmacokinetics of ara-CTP in human leukemic blasts by dipyridamole.
    Yang JL, White JC, Capizzi RL.
    Cancer Chemother Pharmacol; 1992 Jul 01; 29(3):236-40. PubMed ID: 1733557
    [Abstract] [Full Text] [Related]

  • 18. Sequence-dependent interaction of 5-fluorouracil and arabinosyl-5-azacytosine or 1-beta-D-arabinofuranosylcytosine.
    Grem JL, Allegra CJ.
    Biochem Pharmacol; 1991 Jul 05; 42(2):409-18. PubMed ID: 1713459
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacodynamic and DNA methylation studies of high-dose 1-beta-D-arabinofuranosyl cytosine before and after in vivo 5-azacytidine treatment in pediatric patients with refractory acute lymphocytic leukemia.
    Avramis VI, Mecum RA, Nyce J, Steele DA, Holcenberg JS.
    Cancer Chemother Pharmacol; 1989 Jul 05; 24(4):203-10. PubMed ID: 2473850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.